Trials / Active Not Recruiting
Active Not RecruitingNCT05955521
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
Development of a Prognostic and Predictive Biomarker for Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Using Exosome
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study is the experimental study for serial ctDNA and exosome evaluation in EBC patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | exosome and ctDNA evaluation | Serial exosome and ctDNA evaluation during follow up period between neoadjuvant chemotherapy and surveillance after curative surgery. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-07-01
- Completion
- 2028-07-01
- First posted
- 2023-07-21
- Last updated
- 2023-07-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05955521. Inclusion in this directory is not an endorsement.